Company Directory / research

PrivateFor profitresearchPlanegg, Germany
CatalYm is a biotechnology company developing innovative immunotherapies for cancer patients.
Size
11-50 people: larger than 33% of companies with a size listed
Age
10 years old.
Reach
Website ranked #7,334,667 in the world for traffic, about 810 visits a month.
BiotechnologyHealth CareMedicalTherapeutics
Funding, as listed
$261M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about CatalYm, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
CatalYm secured $150 million in a Series D funding round to support the broad Phase 2b development program for Visugromab. Jeito Capital renewed its participation in this financing round.
Summaries written by the source dataset, not by us, and not checked.
research in Germany.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 106,645 companies in Germany and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.